nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisolone—CYP2A6—esophageal cancer	0.574	0.729	CbGaD
Prednisolone—ABCB1—esophageal cancer	0.214	0.271	CbGaD
Prednisolone—SLCO1A2—Methotrexate—esophageal cancer	0.0265	0.593	CbGbCtD
Prednisolone—ABCB1—Cisplatin—esophageal cancer	0.011	0.247	CbGbCtD
Prednisolone—ABCB1—Methotrexate—esophageal cancer	0.00716	0.16	CbGbCtD
Prednisolone—Aseptic necrosis—Methotrexate—esophageal cancer	0.00461	0.0517	CcSEcCtD
Prednisolone—Paraplegia—Methotrexate—esophageal cancer	0.00393	0.0441	CcSEcCtD
Prednisolone—Personality change—Capecitabine—esophageal cancer	0.00372	0.0418	CcSEcCtD
Prednisolone—Diplegia—Methotrexate—esophageal cancer	0.00366	0.0411	CcSEcCtD
Prednisolone—Glucose tolerance impaired—Cisplatin—esophageal cancer	0.0036	0.0404	CcSEcCtD
Prednisolone—Monoplegia—Methotrexate—esophageal cancer	0.00344	0.0386	CcSEcCtD
Prednisolone—Papilloedema—Cisplatin—esophageal cancer	0.00305	0.0342	CcSEcCtD
Prednisolone—Arachnoiditis—Methotrexate—esophageal cancer	0.00291	0.0327	CcSEcCtD
Prednisolone—Amcinonide—ANXA1—esophageal cancer	0.00158	0.223	CrCbGaD
Prednisolone—Optic neuritis—Cisplatin—esophageal cancer	0.00157	0.0177	CcSEcCtD
Prednisolone—Osteonecrosis—Methotrexate—esophageal cancer	0.00143	0.016	CcSEcCtD
Prednisolone—Leukoderma—Methotrexate—esophageal cancer	0.00125	0.014	CcSEcCtD
Prednisolone—Impaired healing—Methotrexate—esophageal cancer	0.00123	0.0138	CcSEcCtD
Prednisolone—Hirsutism—Capecitabine—esophageal cancer	0.00123	0.0138	CcSEcCtD
Prednisolone—Abscess—Cisplatin—esophageal cancer	0.00122	0.0137	CcSEcCtD
Prednisolone—Embolism—Capecitabine—esophageal cancer	0.00111	0.0125	CcSEcCtD
Prednisolone—Keratitis—Capecitabine—esophageal cancer	0.0011	0.0124	CcSEcCtD
Prednisolone—Hepatomegaly—Capecitabine—esophageal cancer	0.00101	0.0113	CcSEcCtD
Prednisolone—Pain—Carboplatin—esophageal cancer	0.00101	0.0113	CcSEcCtD
Prednisolone—Blister—Capecitabine—esophageal cancer	0.00099	0.0111	CcSEcCtD
Prednisolone—Hiccups—Cisplatin—esophageal cancer	0.000968	0.0109	CcSEcCtD
Prednisolone—Osteoporosis—Methotrexate—esophageal cancer	0.000948	0.0106	CcSEcCtD
Prednisolone—Fluid retention—Cisplatin—esophageal cancer	0.000919	0.0103	CcSEcCtD
Prednisolone—Neuropathy—Cisplatin—esophageal cancer	0.000909	0.0102	CcSEcCtD
Prednisolone—Petechiae—Capecitabine—esophageal cancer	0.000868	0.00974	CcSEcCtD
Prednisolone—Eye irritation—Capecitabine—esophageal cancer	0.000836	0.00938	CcSEcCtD
Prednisolone—Embolism—Methotrexate—esophageal cancer	0.000828	0.00929	CcSEcCtD
Prednisolone—Cardiac failure congestive—Cisplatin—esophageal cancer	0.000775	0.0087	CcSEcCtD
Prednisolone—Herpes simplex—Capecitabine—esophageal cancer	0.000775	0.00869	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Cisplatin—esophageal cancer	0.000726	0.00815	CcSEcCtD
Prednisolone—Hiccups—Capecitabine—esophageal cancer	0.000714	0.00801	CcSEcCtD
Prednisolone—Fluid retention—Capecitabine—esophageal cancer	0.000678	0.00761	CcSEcCtD
Prednisolone—Abscess—Methotrexate—esophageal cancer	0.000672	0.00754	CcSEcCtD
Prednisolone—Neuropathy—Capecitabine—esophageal cancer	0.00067	0.00752	CcSEcCtD
Prednisolone—Exemestane—CYP19A1—esophageal cancer	0.000668	0.0939	CrCbGaD
Prednisolone—Hydrocortisone—ANXA1—esophageal cancer	0.000668	0.0939	CrCbGaD
Prednisolone—Petechiae—Methotrexate—esophageal cancer	0.000646	0.00725	CcSEcCtD
Prednisolone—Ecchymosis—Capecitabine—esophageal cancer	0.000645	0.00724	CcSEcCtD
Prednisolone—Testolactone—CYP19A1—esophageal cancer	0.000637	0.0896	CrCbGaD
Prednisolone—Thrombophlebitis—Capecitabine—esophageal cancer	0.000599	0.00672	CcSEcCtD
Prednisolone—Diabetes mellitus—Capecitabine—esophageal cancer	0.000596	0.00669	CcSEcCtD
Prednisolone—Pancreatitis—Cisplatin—esophageal cancer	0.000596	0.00669	CcSEcCtD
Prednisolone—Sweating increased—Cisplatin—esophageal cancer	0.000592	0.00664	CcSEcCtD
Prednisolone—Herpes simplex—Methotrexate—esophageal cancer	0.000577	0.00647	CcSEcCtD
Prednisolone—Increased appetite—Capecitabine—esophageal cancer	0.000551	0.00619	CcSEcCtD
Prednisolone—Vasculitis—Methotrexate—esophageal cancer	0.000544	0.00611	CcSEcCtD
Prednisolone—Dermatitis bullous—Capecitabine—esophageal cancer	0.000542	0.00609	CcSEcCtD
Prednisolone—Acute coronary syndrome—Cisplatin—esophageal cancer	0.000534	0.00599	CcSEcCtD
Prednisolone—Myocardial infarction—Cisplatin—esophageal cancer	0.000531	0.00596	CcSEcCtD
Prednisolone—Neuropathy peripheral—Cisplatin—esophageal cancer	0.000531	0.00596	CcSEcCtD
Prednisolone—Conjunctivitis—Cisplatin—esophageal cancer	0.000527	0.00591	CcSEcCtD
Prednisolone—Osteoarthritis—Capecitabine—esophageal cancer	0.000518	0.00582	CcSEcCtD
Prednisolone—Dexamethasone—ANXA1—esophageal cancer	0.000498	0.07	CrCbGaD
Prednisolone—Bradycardia—Cisplatin—esophageal cancer	0.000495	0.00556	CcSEcCtD
Prednisolone—Cardiac arrest—Capecitabine—esophageal cancer	0.000493	0.00553	CcSEcCtD
Prednisolone—Mood swings—Capecitabine—esophageal cancer	0.000491	0.00551	CcSEcCtD
Prednisolone—Ecchymosis—Methotrexate—esophageal cancer	0.00048	0.00539	CcSEcCtD
Prednisolone—Dry skin—Capecitabine—esophageal cancer	0.000475	0.00533	CcSEcCtD
Prednisolone—Pulmonary oedema—Methotrexate—esophageal cancer	0.000473	0.00531	CcSEcCtD
Prednisolone—Visual impairment—Cisplatin—esophageal cancer	0.000469	0.00526	CcSEcCtD
Prednisolone—Muscular weakness—Capecitabine—esophageal cancer	0.000457	0.00513	CcSEcCtD
Prednisolone—Abdominal distension—Capecitabine—esophageal cancer	0.000451	0.00506	CcSEcCtD
Prednisolone—Thrombophlebitis—Methotrexate—esophageal cancer	0.000446	0.005	CcSEcCtD
Prednisolone—Diabetes mellitus—Methotrexate—esophageal cancer	0.000443	0.00498	CcSEcCtD
Prednisolone—Sweating increased—Capecitabine—esophageal cancer	0.000436	0.0049	CcSEcCtD
Prednisolone—Arrhythmia—Cisplatin—esophageal cancer	0.000434	0.00488	CcSEcCtD
Prednisolone—Erythema—Cisplatin—esophageal cancer	0.000423	0.00475	CcSEcCtD
Prednisolone—Weight increased—Capecitabine—esophageal cancer	0.000408	0.00457	CcSEcCtD
Prednisolone—Visual disturbance—Methotrexate—esophageal cancer	0.000407	0.00457	CcSEcCtD
Prednisolone—Vision blurred—Cisplatin—esophageal cancer	0.000399	0.00448	CcSEcCtD
Prednisolone—Anaphylactoid reaction—Methotrexate—esophageal cancer	0.000399	0.00447	CcSEcCtD
Prednisolone—Acute coronary syndrome—Capecitabine—esophageal cancer	0.000394	0.00442	CcSEcCtD
Prednisolone—Ill-defined disorder—Cisplatin—esophageal cancer	0.000393	0.00441	CcSEcCtD
Prednisolone—Neuropathy peripheral—Capecitabine—esophageal cancer	0.000391	0.00439	CcSEcCtD
Prednisolone—Myocardial infarction—Capecitabine—esophageal cancer	0.000391	0.00439	CcSEcCtD
Prednisolone—Conjunctivitis—Capecitabine—esophageal cancer	0.000388	0.00436	CcSEcCtD
Prednisolone—Osteoarthritis—Methotrexate—esophageal cancer	0.000386	0.00433	CcSEcCtD
Prednisolone—Malaise—Cisplatin—esophageal cancer	0.000382	0.00428	CcSEcCtD
Prednisolone—Convulsion—Cisplatin—esophageal cancer	0.000367	0.00412	CcSEcCtD
Prednisolone—Mood swings—Methotrexate—esophageal cancer	0.000365	0.0041	CcSEcCtD
Prednisolone—Bradycardia—Capecitabine—esophageal cancer	0.000365	0.0041	CcSEcCtD
Prednisolone—Haemoglobin—Capecitabine—esophageal cancer	0.00036	0.00404	CcSEcCtD
Prednisolone—Haemorrhage—Capecitabine—esophageal cancer	0.000358	0.00402	CcSEcCtD
Prednisolone—Discomfort—Cisplatin—esophageal cancer	0.000356	0.004	CcSEcCtD
Prednisolone—Anaphylactic shock—Cisplatin—esophageal cancer	0.000345	0.00388	CcSEcCtD
Prednisolone—Oedema—Cisplatin—esophageal cancer	0.000345	0.00388	CcSEcCtD
Prednisolone—Visual impairment—Capecitabine—esophageal cancer	0.000345	0.00388	CcSEcCtD
Prednisolone—Tachycardia—Cisplatin—esophageal cancer	0.000337	0.00378	CcSEcCtD
Prednisolone—Hyperhidrosis—Cisplatin—esophageal cancer	0.000334	0.00375	CcSEcCtD
Prednisolone—Pancreatitis—Methotrexate—esophageal cancer	0.000327	0.00367	CcSEcCtD
Prednisolone—Arrhythmia—Capecitabine—esophageal cancer	0.00032	0.00359	CcSEcCtD
Prednisolone—Erythema—Capecitabine—esophageal cancer	0.000312	0.0035	CcSEcCtD
Prednisolone—Paraesthesia—Cisplatin—esophageal cancer	0.00031	0.00348	CcSEcCtD
Prednisolone—Pain—Cisplatin—esophageal cancer	0.000295	0.00332	CcSEcCtD
Prednisolone—Vision blurred—Capecitabine—esophageal cancer	0.000294	0.0033	CcSEcCtD
Prednisolone—Ill-defined disorder—Capecitabine—esophageal cancer	0.00029	0.00325	CcSEcCtD
Prednisolone—Conjunctivitis—Methotrexate—esophageal cancer	0.000289	0.00324	CcSEcCtD
Prednisolone—Feeling abnormal—Cisplatin—esophageal cancer	0.000285	0.0032	CcSEcCtD
Prednisolone—Malaise—Capecitabine—esophageal cancer	0.000281	0.00316	CcSEcCtD
Prednisolone—Vertigo—Capecitabine—esophageal cancer	0.00028	0.00315	CcSEcCtD
Prednisolone—Syncope—Capecitabine—esophageal cancer	0.00028	0.00314	CcSEcCtD
Prednisolone—Loss of consciousness—Capecitabine—esophageal cancer	0.000274	0.00308	CcSEcCtD
Prednisolone—Hypertension—Capecitabine—esophageal cancer	0.000269	0.00302	CcSEcCtD
Prednisolone—Haemoglobin—Methotrexate—esophageal cancer	0.000268	0.00301	CcSEcCtD
Prednisolone—Haemorrhage—Methotrexate—esophageal cancer	0.000267	0.003	CcSEcCtD
Prednisolone—Discomfort—Capecitabine—esophageal cancer	0.000262	0.00295	CcSEcCtD
Prednisolone—Methyltestosterone—CYP19A1—esophageal cancer	0.000259	0.0364	CrCbGaD
Prednisolone—Visual impairment—Methotrexate—esophageal cancer	0.000257	0.00289	CcSEcCtD
Prednisolone—Oedema—Capecitabine—esophageal cancer	0.000255	0.00286	CcSEcCtD
Prednisolone—Hypersensitivity—Cisplatin—esophageal cancer	0.000255	0.00286	CcSEcCtD
Prednisolone—Shock—Capecitabine—esophageal cancer	0.000251	0.00281	CcSEcCtD
Prednisolone—Betamethasone—CYP19A1—esophageal cancer	0.00025	0.0352	CrCbGaD
Prednisolone—Tachycardia—Capecitabine—esophageal cancer	0.000249	0.00279	CcSEcCtD
Prednisolone—Hyperhidrosis—Capecitabine—esophageal cancer	0.000246	0.00276	CcSEcCtD
Prednisolone—Dexamethasone—NOS2—esophageal cancer	0.000233	0.0328	CrCbGaD
Prednisolone—Erythema—Methotrexate—esophageal cancer	0.000232	0.00261	CcSEcCtD
Prednisolone—Insomnia—Capecitabine—esophageal cancer	0.00023	0.00259	CcSEcCtD
Prednisolone—Paraesthesia—Capecitabine—esophageal cancer	0.000229	0.00257	CcSEcCtD
Prednisolone—Vision blurred—Methotrexate—esophageal cancer	0.000219	0.00246	CcSEcCtD
Prednisolone—Rash—Cisplatin—esophageal cancer	0.000218	0.00245	CcSEcCtD
Prednisolone—Pain—Capecitabine—esophageal cancer	0.000218	0.00244	CcSEcCtD
Prednisolone—Dermatitis—Cisplatin—esophageal cancer	0.000218	0.00244	CcSEcCtD
Prednisolone—Progesterone—CYP1B1—esophageal cancer	0.000217	0.0305	CrCbGaD
Prednisolone—Ill-defined disorder—Methotrexate—esophageal cancer	0.000216	0.00242	CcSEcCtD
Prednisolone—Feeling abnormal—Capecitabine—esophageal cancer	0.00021	0.00236	CcSEcCtD
Prednisolone—Malaise—Methotrexate—esophageal cancer	0.000209	0.00235	CcSEcCtD
Prednisolone—Vertigo—Methotrexate—esophageal cancer	0.000209	0.00234	CcSEcCtD
Prednisolone—Nausea—Cisplatin—esophageal cancer	0.000205	0.0023	CcSEcCtD
Prednisolone—Testosterone—CYP1B1—esophageal cancer	0.000205	0.0288	CrCbGaD
Prednisolone—Urticaria—Capecitabine—esophageal cancer	0.000202	0.00227	CcSEcCtD
Prednisolone—NR3C2—bronchus—esophageal cancer	0.000202	0.0787	CbGeAlD
Prednisolone—Convulsion—Methotrexate—esophageal cancer	0.000201	0.00226	CcSEcCtD
Prednisolone—Dexamethasone—CYP1B1—esophageal cancer	0.000198	0.0279	CrCbGaD
Prednisolone—NR3C2—smooth muscle tissue—esophageal cancer	0.000197	0.077	CbGeAlD
Prednisolone—Discomfort—Methotrexate—esophageal cancer	0.000195	0.00219	CcSEcCtD
Prednisolone—Anaphylactic shock—Methotrexate—esophageal cancer	0.00019	0.00213	CcSEcCtD
Prednisolone—Hypersensitivity—Capecitabine—esophageal cancer	0.000188	0.00211	CcSEcCtD
Prednisolone—Hyperhidrosis—Methotrexate—esophageal cancer	0.000183	0.00206	CcSEcCtD
Prednisolone—NR3C2—trachea—esophageal cancer	0.000181	0.0707	CbGeAlD
Prednisolone—Insomnia—Methotrexate—esophageal cancer	0.000171	0.00192	CcSEcCtD
Prednisolone—Paraesthesia—Methotrexate—esophageal cancer	0.00017	0.00191	CcSEcCtD
Prednisolone—Dizziness—Capecitabine—esophageal cancer	0.000168	0.00189	CcSEcCtD
Prednisolone—Progesterone—CYP2A6—esophageal cancer	0.000167	0.0235	CrCbGaD
Prednisolone—Pain—Methotrexate—esophageal cancer	0.000162	0.00182	CcSEcCtD
Prednisolone—NR3C1—neck—esophageal cancer	0.000162	0.063	CbGeAlD
Prednisolone—Rash—Capecitabine—esophageal cancer	0.000161	0.0018	CcSEcCtD
Prednisolone—Dermatitis—Capecitabine—esophageal cancer	0.00016	0.0018	CcSEcCtD
Prednisolone—Headache—Capecitabine—esophageal cancer	0.00016	0.00179	CcSEcCtD
Prednisolone—SERPINA6—lung—esophageal cancer	0.000159	0.0622	CbGeAlD
Prednisolone—Feeling abnormal—Methotrexate—esophageal cancer	0.000156	0.00175	CcSEcCtD
Prednisolone—NR3C2—digestive system—esophageal cancer	0.000156	0.0608	CbGeAlD
Prednisolone—Dexamethasone—ABCC2—esophageal cancer	0.000155	0.0217	CrCbGaD
Prednisolone—Dexamethasone—CYP2A6—esophageal cancer	0.000153	0.0215	CrCbGaD
Prednisolone—Nausea—Capecitabine—esophageal cancer	0.000151	0.0017	CcSEcCtD
Prednisolone—Urticaria—Methotrexate—esophageal cancer	0.000151	0.00169	CcSEcCtD
Prednisolone—Testosterone—CYP19A1—esophageal cancer	0.00015	0.0211	CrCbGaD
Prednisolone—Dexamethasone—CYP19A1—esophageal cancer	0.000145	0.0205	CrCbGaD
Prednisolone—Methylprednisolone—ABCB1—esophageal cancer	0.000142	0.0199	CrCbGaD
Prednisolone—Triamcinolone—PTGS2—esophageal cancer	0.00014	0.0197	CrCbGaD
Prednisolone—Hypersensitivity—Methotrexate—esophageal cancer	0.00014	0.00157	CcSEcCtD
Prednisolone—CYP2A6—lung—esophageal cancer	0.000139	0.0542	CbGeAlD
Prednisolone—SLCO1A2—digestive system—esophageal cancer	0.000134	0.0521	CbGeAlD
Prednisolone—NR3C2—lung—esophageal cancer	0.00013	0.0508	CbGeAlD
Prednisolone—Dizziness—Methotrexate—esophageal cancer	0.000125	0.00141	CcSEcCtD
Prednisolone—CYP3A4—Tryptophan metabolism—CYP19A1—esophageal cancer	0.00012	0.00174	CbGpPWpGaD
Prednisolone—Rash—Methotrexate—esophageal cancer	0.00012	0.00134	CcSEcCtD
Prednisolone—Dermatitis—Methotrexate—esophageal cancer	0.000119	0.00134	CcSEcCtD
Prednisolone—CYP2A6—NRF2 pathway—HMOX1—esophageal cancer	0.000119	0.00172	CbGpPWpGaD
Prednisolone—Headache—Methotrexate—esophageal cancer	0.000119	0.00133	CcSEcCtD
Prednisolone—Betamethasone—PTGS2—esophageal cancer	0.000115	0.0162	CrCbGaD
Prednisolone—CYP2A6—Biological oxidations—CYP19A1—esophageal cancer	0.000114	0.00166	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—HIF1A—esophageal cancer	0.000114	0.00165	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BBC3—esophageal cancer	0.000113	0.00164	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—CCND1—esophageal cancer	0.000113	0.00163	CbGpPWpGaD
Prednisolone—Nausea—Methotrexate—esophageal cancer	0.000113	0.00126	CcSEcCtD
Prednisolone—SLCO1A2—lung—esophageal cancer	0.000112	0.0435	CbGeAlD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—ALDH2—esophageal cancer	0.000111	0.0016	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—ALOX15—esophageal cancer	0.00011	0.0016	CbGpPWpGaD
Prednisolone—NR3C1—epithelium—esophageal cancer	0.00011	0.0429	CbGeAlD
Prednisolone—Prednisone—ABCB1—esophageal cancer	0.000108	0.0152	CrCbGaD
Prednisolone—NR3C1—bronchus—esophageal cancer	0.000108	0.0422	CbGeAlD
Prednisolone—NR3C1—Generic Transcription Pathway—NR1I2—esophageal cancer	0.000107	0.00155	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—NOTCH1—esophageal cancer	0.000106	0.00154	CbGpPWpGaD
Prednisolone—NR3C1—smooth muscle tissue—esophageal cancer	0.000106	0.0413	CbGeAlD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—HIF1A—esophageal cancer	0.000105	0.00152	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—esophageal cancer	0.000104	0.00151	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—EP300—esophageal cancer	0.000104	0.0015	CbGpPWpGaD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—esophageal cancer	0.000104	0.0015	CbGpPWpGaD
Prednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—esophageal cancer	0.000102	0.00148	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—esophageal cancer	9.87e-05	0.00143	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—HIF1A—esophageal cancer	9.81e-05	0.00142	CbGpPWpGaD
Prednisolone—Betamethasone—ABCB1—esophageal cancer	9.78e-05	0.0137	CrCbGaD
Prednisolone—NR3C2—Gene Expression—PSME2—esophageal cancer	9.75e-05	0.00141	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—PSME1—esophageal cancer	9.75e-05	0.00141	CbGpPWpGaD
Prednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—esophageal cancer	9.73e-05	0.00141	CbGpPWpGaD
Prednisolone—NR3C1—trachea—esophageal cancer	9.72e-05	0.0379	CbGeAlD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—esophageal cancer	9.69e-05	0.0014	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—CREBBP—esophageal cancer	9.62e-05	0.00139	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CRABP1—esophageal cancer	9.61e-05	0.00139	CbGpPWpGaD
Prednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—esophageal cancer	9.61e-05	0.00139	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—esophageal cancer	9.6e-05	0.00139	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—ABCC2—esophageal cancer	9.58e-05	0.00139	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—NOS2—esophageal cancer	9.54e-05	0.00138	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—ADH7—esophageal cancer	9.52e-05	0.00138	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—RB1—esophageal cancer	9.24e-05	0.00134	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—esophageal cancer	9.22e-05	0.00134	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NOTCH3—esophageal cancer	9.2e-05	0.00133	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—EP300—esophageal cancer	9.13e-05	0.00132	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—MYC—esophageal cancer	9.03e-05	0.00131	CbGpPWpGaD
Prednisolone—NR3C2—lymph node—esophageal cancer	8.91e-05	0.0347	CbGeAlD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—GNG7—esophageal cancer	8.69e-05	0.00126	CbGpPWpGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—CREBBP—esophageal cancer	8.57e-05	0.00124	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—BLVRB—esophageal cancer	8.54e-05	0.00124	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—SLC52A3—esophageal cancer	8.54e-05	0.00124	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—esophageal cancer	8.39e-05	0.00122	CbGpPWpGaD
Prednisolone—NR3C1—digestive system—esophageal cancer	8.36e-05	0.0326	CbGeAlD
Prednisolone—CYP3A4—Biological oxidations—ADH1B—esophageal cancer	8.35e-05	0.00121	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NOTCH2—esophageal cancer	8.25e-05	0.0012	CbGpPWpGaD
Prednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—esophageal cancer	8.04e-05	0.00116	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—CREBBP—esophageal cancer	8.02e-05	0.00116	CbGpPWpGaD
Prednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—esophageal cancer	7.89e-05	0.00114	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—CYP26A1—esophageal cancer	7.76e-05	0.00112	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—esophageal cancer	7.68e-05	0.00111	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP26A1—esophageal cancer	7.66e-05	0.00111	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS1—esophageal cancer	7.63e-05	0.00111	CbGpPWpGaD
Prednisolone—Hydrocortisone—ABCB1—esophageal cancer	7.63e-05	0.0107	CrCbGaD
Prednisolone—ABCB1—Allograft Rejection—CASP8—esophageal cancer	7.46e-05	0.00108	CbGpPWpGaD
Prednisolone—NR3C1—AP-1 transcription factor network—TP53—esophageal cancer	7.42e-05	0.00107	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CA1—esophageal cancer	7.26e-05	0.00105	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—SLC10A2—esophageal cancer	7.26e-05	0.00105	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—GSTO1—esophageal cancer	7.22e-05	0.00105	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—GSTO1—esophageal cancer	7.12e-05	0.00103	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BUB1B—esophageal cancer	7.02e-05	0.00102	CbGpPWpGaD
Prednisolone—NR3C1—lung—esophageal cancer	6.98e-05	0.0272	CbGeAlD
Prednisolone—NR3C2—Gene Expression—SMAD4—esophageal cancer	6.93e-05	0.001	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—SMG6—esophageal cancer	6.81e-05	0.000986	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NOTCH3—esophageal cancer	6.73e-05	0.000975	CbGpPWpGaD
Prednisolone—Dexamethasone—PTGS2—esophageal cancer	6.69e-05	0.0094	CrCbGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—esophageal cancer	6.68e-05	0.000967	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CA2—esophageal cancer	6.64e-05	0.000962	CbGpPWpGaD
Prednisolone—NR3C1—Adipogenesis—CDKN1A—esophageal cancer	6.64e-05	0.000962	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC10A2—esophageal cancer	6.64e-05	0.000962	CbGpPWpGaD
Prednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—esophageal cancer	6.54e-05	0.000947	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP1B1—esophageal cancer	6.49e-05	0.00094	CbGpPWpGaD
Prednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—esophageal cancer	6.45e-05	0.000935	CbGpPWpGaD
Prednisolone—CYP3A4—digestive system—esophageal cancer	6.32e-05	0.0247	CbGeAlD
Prednisolone—ABCB1—Transmembrane transport of small molecules—ATP1B2—esophageal cancer	6.24e-05	0.000904	CbGpPWpGaD
Prednisolone—Progesterone—ABCB1—esophageal cancer	6.22e-05	0.00874	CrCbGaD
Prednisolone—SLCO1A2—Metabolism—ADH7—esophageal cancer	6.17e-05	0.000895	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PLCE1—esophageal cancer	6.17e-05	0.000895	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SLC52A3—esophageal cancer	6.14e-05	0.00089	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—BLVRB—esophageal cancer	6.14e-05	0.00089	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—esophageal cancer	6.1e-05	0.000884	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—NOTCH2—esophageal cancer	6.03e-05	0.000874	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC39A6—esophageal cancer	5.92e-05	0.000857	CbGpPWpGaD
Prednisolone—ABCB1—epithelium—esophageal cancer	5.88e-05	0.0229	CbGeAlD
Prednisolone—CYP3A4—Biological oxidations—ALDH2—esophageal cancer	5.88e-05	0.000852	CbGpPWpGaD
Prednisolone—Testosterone—ABCB1—esophageal cancer	5.88e-05	0.00827	CrCbGaD
Prednisolone—ABCB1—HIF-1-alpha transcription factor network—EP300—esophageal cancer	5.84e-05	0.000846	CbGpPWpGaD
Prednisolone—NR3C2—Generic Transcription Pathway—MYC—esophageal cancer	5.71e-05	0.000827	CbGpPWpGaD
Prednisolone—Dexamethasone—ABCB1—esophageal cancer	5.69e-05	0.008	CrCbGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—esophageal cancer	5.66e-05	0.00082	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—AQP3—esophageal cancer	5.64e-05	0.000818	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—GSTT1—esophageal cancer	5.6e-05	0.000811	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—CYP2A6—esophageal cancer	5.53e-05	0.000801	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—esophageal cancer	5.48e-05	0.000794	CbGpPWpGaD
Prednisolone—NR3C1—SIDS Susceptibility Pathways—EP300—esophageal cancer	5.46e-05	0.000791	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ADH1B—esophageal cancer	5.41e-05	0.000784	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—SLC30A7—esophageal cancer	5.41e-05	0.000784	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—ATP4A—esophageal cancer	5.41e-05	0.000784	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—HMOX1—esophageal cancer	5.3e-05	0.000767	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—PTGS1—esophageal cancer	5.24e-05	0.00076	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CA1—esophageal cancer	5.22e-05	0.000757	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—SLC10A2—esophageal cancer	5.22e-05	0.000757	CbGpPWpGaD
Prednisolone—ABCB1—trachea—esophageal cancer	5.2e-05	0.0203	CbGeAlD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—esophageal cancer	5.18e-05	0.000751	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—TYMP—esophageal cancer	5.17e-05	0.00075	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NR1I2—esophageal cancer	5.16e-05	0.000747	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—NOTCH1—esophageal cancer	5.11e-05	0.00074	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—ABCB1—esophageal cancer	5.08e-05	0.000736	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—SMAD4—esophageal cancer	5.07e-05	0.000734	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP26A1—esophageal cancer	5.03e-05	0.000729	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ALOX15—esophageal cancer	4.91e-05	0.000711	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CA2—esophageal cancer	4.78e-05	0.000692	CbGpPWpGaD
Prednisolone—NR3C1—lymph node—esophageal cancer	4.78e-05	0.0186	CbGeAlD
Prednisolone—SLCO1A2—Metabolism—TPI1—esophageal cancer	4.68e-05	0.000678	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GSTO1—esophageal cancer	4.68e-05	0.000678	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—CREBBP—esophageal cancer	4.63e-05	0.000671	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ALDOB—esophageal cancer	4.49e-05	0.00065	CbGpPWpGaD
Prednisolone—ABCB1—digestive system—esophageal cancer	4.48e-05	0.0175	CbGeAlD
Prednisolone—CYP3A4—Biological oxidations—CYP1B1—esophageal cancer	4.46e-05	0.000646	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ADH7—esophageal cancer	4.44e-05	0.000643	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PLCE1—esophageal cancer	4.44e-05	0.000643	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—HIST1H2BM—esophageal cancer	4.43e-05	0.000641	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP1B1—esophageal cancer	4.4e-05	0.000637	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GAPDH—esophageal cancer	4.32e-05	0.000626	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CRABP1—esophageal cancer	4.28e-05	0.00062	CbGpPWpGaD
Prednisolone—CYP3A4—Biological oxidations—CYP19A1—esophageal cancer	4.19e-05	0.000607	CbGpPWpGaD
Prednisolone—CYP3A4—Metapathway biotransformation—CYP19A1—esophageal cancer	4.13e-05	0.000599	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—ABCC2—esophageal cancer	4.1e-05	0.000594	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GNG7—esophageal cancer	4.07e-05	0.00059	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ADH1B—esophageal cancer	3.89e-05	0.000564	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ALDH2—esophageal cancer	3.81e-05	0.000553	CbGpPWpGaD
Prednisolone—ABCB1—lung—esophageal cancer	3.74e-05	0.0146	CbGeAlD
Prednisolone—NR3C1—Generic Transcription Pathway—NOTCH1—esophageal cancer	3.74e-05	0.000541	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—TYMP—esophageal cancer	3.72e-05	0.000539	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—GNG7—esophageal cancer	3.72e-05	0.000539	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—esophageal cancer	3.68e-05	0.000533	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—esophageal cancer	3.66e-05	0.000531	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SLC52A3—esophageal cancer	3.66e-05	0.00053	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—BLVRB—esophageal cancer	3.66e-05	0.00053	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—GSTT1—esophageal cancer	3.63e-05	0.000526	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP26A1—esophageal cancer	3.62e-05	0.000525	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP2A6—esophageal cancer	3.59e-05	0.00052	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—CREBBP—esophageal cancer	3.57e-05	0.000518	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ALOX15—esophageal cancer	3.53e-05	0.000511	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PSME1—esophageal cancer	3.43e-05	0.000497	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—PSME2—esophageal cancer	3.43e-05	0.000497	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTGS1—esophageal cancer	3.4e-05	0.000493	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ENO1—esophageal cancer	3.4e-05	0.000493	CbGpPWpGaD
Prednisolone—SLCO1A2—Transmembrane transport of small molecules—CREBBP—esophageal cancer	3.4e-05	0.000492	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—CREBBP—esophageal cancer	3.39e-05	0.000491	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GSTO1—esophageal cancer	3.37e-05	0.000488	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—TPI1—esophageal cancer	3.37e-05	0.000488	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PSME2—esophageal cancer	3.35e-05	0.000485	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PSME1—esophageal cancer	3.35e-05	0.000485	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NOTCH3—esophageal cancer	3.24e-05	0.000469	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ALDOB—esophageal cancer	3.23e-05	0.000468	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—esophageal cancer	3.16e-05	0.000457	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—SLC10A2—esophageal cancer	3.11e-05	0.00045	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CA1—esophageal cancer	3.11e-05	0.00045	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GAPDH—esophageal cancer	3.11e-05	0.00045	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CRABP1—esophageal cancer	3.08e-05	0.000446	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—esophageal cancer	3.07e-05	0.000444	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—esophageal cancer	3e-05	0.000435	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GNG7—esophageal cancer	2.93e-05	0.000424	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—esophageal cancer	2.93e-05	0.000424	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NOTCH2—esophageal cancer	2.91e-05	0.000421	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP1B1—esophageal cancer	2.89e-05	0.000419	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CA2—esophageal cancer	2.84e-05	0.000412	CbGpPWpGaD
Prednisolone—NR3C2—Gene Expression—MYC—esophageal cancer	2.75e-05	0.000398	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ALDH2—esophageal cancer	2.74e-05	0.000398	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CYP19A1—esophageal cancer	2.72e-05	0.000394	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—esophageal cancer	2.71e-05	0.000393	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ADH7—esophageal cancer	2.64e-05	0.000383	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PLCE1—esophageal cancer	2.64e-05	0.000383	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—esophageal cancer	2.62e-05	0.00038	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—GSTT1—esophageal cancer	2.61e-05	0.000378	CbGpPWpGaD
Prednisolone—ABCB1—lymph node—esophageal cancer	2.56e-05	0.00997	CbGeAlD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—esophageal cancer	2.49e-05	0.000361	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—HMOX1—esophageal cancer	2.48e-05	0.000359	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ENO1—esophageal cancer	2.45e-05	0.000354	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTGS1—esophageal cancer	2.45e-05	0.000354	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—SMAD4—esophageal cancer	2.44e-05	0.000353	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—esophageal cancer	2.43e-05	0.000353	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PSME2—esophageal cancer	2.41e-05	0.000349	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PSME1—esophageal cancer	2.41e-05	0.000349	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—ABCB1—esophageal cancer	2.38e-05	0.000345	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ADH1B—esophageal cancer	2.32e-05	0.000336	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—HMOX1—esophageal cancer	2.27e-05	0.000328	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SLC52A3—esophageal cancer	2.25e-05	0.000326	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—BLVRB—esophageal cancer	2.25e-05	0.000326	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—TYMP—esophageal cancer	2.22e-05	0.000321	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—esophageal cancer	2.17e-05	0.000315	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP26A1—esophageal cancer	2.15e-05	0.000312	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—esophageal cancer	2.13e-05	0.000308	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ALOX15—esophageal cancer	2.1e-05	0.000304	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP1B1—esophageal cancer	2.08e-05	0.000301	CbGpPWpGaD
Prednisolone—NR3C1—Generic Transcription Pathway—MYC—esophageal cancer	2.01e-05	0.000291	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GSTO1—esophageal cancer	2e-05	0.00029	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—TPI1—esophageal cancer	2e-05	0.00029	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CYP19A1—esophageal cancer	1.96e-05	0.000283	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ALDOB—esophageal cancer	1.92e-05	0.000278	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—SLC10A2—esophageal cancer	1.92e-05	0.000277	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CA1—esophageal cancer	1.92e-05	0.000277	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GAPDH—esophageal cancer	1.85e-05	0.000268	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—esophageal cancer	1.85e-05	0.000267	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CRABP1—esophageal cancer	1.83e-05	0.000265	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—esophageal cancer	1.8e-05	0.000261	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—NOTCH1—esophageal cancer	1.8e-05	0.000261	CbGpPWpGaD
Prednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—esophageal cancer	1.79e-05	0.000259	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—HMOX1—esophageal cancer	1.78e-05	0.000258	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CA2—esophageal cancer	1.75e-05	0.000254	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GNG7—esophageal cancer	1.74e-05	0.000252	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—ABCB1—esophageal cancer	1.71e-05	0.000248	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ALDH2—esophageal cancer	1.63e-05	0.000237	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—CREBBP—esophageal cancer	1.63e-05	0.000236	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ADH7—esophageal cancer	1.63e-05	0.000236	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PLCE1—esophageal cancer	1.63e-05	0.000236	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—CREBBP—esophageal cancer	1.59e-05	0.000231	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—GSTT1—esophageal cancer	1.55e-05	0.000225	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP2A6—esophageal cancer	1.54e-05	0.000222	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTGS1—esophageal cancer	1.46e-05	0.000211	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—ENO1—esophageal cancer	1.46e-05	0.000211	CbGpPWpGaD
Prednisolone—ABCB1—Transmembrane transport of small molecules—CREBBP—esophageal cancer	1.45e-05	0.000211	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PSME1—esophageal cancer	1.43e-05	0.000208	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PSME2—esophageal cancer	1.43e-05	0.000208	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ADH1B—esophageal cancer	1.43e-05	0.000207	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—NOS3—esophageal cancer	1.42e-05	0.000206	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—TYMP—esophageal cancer	1.36e-05	0.000198	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP26A1—esophageal cancer	1.33e-05	0.000192	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PTGS2—esophageal cancer	1.3e-05	0.000189	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ALOX15—esophageal cancer	1.29e-05	0.000187	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP1B1—esophageal cancer	1.24e-05	0.000179	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—TPI1—esophageal cancer	1.23e-05	0.000179	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GSTO1—esophageal cancer	1.23e-05	0.000179	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ALDOB—esophageal cancer	1.18e-05	0.000171	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CYP19A1—esophageal cancer	1.16e-05	0.000169	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—CREBBP—esophageal cancer	1.14e-05	0.000166	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GAPDH—esophageal cancer	1.14e-05	0.000165	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CRABP1—esophageal cancer	1.13e-05	0.000164	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—EP300—esophageal cancer	1.08e-05	0.000157	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GNG7—esophageal cancer	1.07e-05	0.000156	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—HMOX1—esophageal cancer	1.06e-05	0.000154	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—NOS3—esophageal cancer	1.02e-05	0.000148	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ALDH2—esophageal cancer	1.01e-05	0.000146	CbGpPWpGaD
Prednisolone—NR3C1—Gene Expression—MYC—esophageal cancer	9.68e-06	0.00014	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—GSTT1—esophageal cancer	9.57e-06	0.000139	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP2A6—esophageal cancer	9.46e-06	0.000137	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PTGS2—esophageal cancer	9.37e-06	0.000136	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTGS1—esophageal cancer	8.97e-06	0.00013	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ENO1—esophageal cancer	8.97e-06	0.00013	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PSME1—esophageal cancer	8.84e-06	0.000128	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PSME2—esophageal cancer	8.84e-06	0.000128	CbGpPWpGaD
Prednisolone—SLCO1A2—Metabolism—PIK3CA—esophageal cancer	8.02e-06	0.000116	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—EP300—esophageal cancer	7.8e-06	0.000113	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP1B1—esophageal cancer	7.62e-06	0.00011	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CYP19A1—esophageal cancer	7.17e-06	0.000104	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—CREBBP—esophageal cancer	6.81e-06	9.87e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—HMOX1—esophageal cancer	6.54e-06	9.48e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—ABCB1—esophageal cancer	6.28e-06	9.1e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—NOS3—esophageal cancer	6.1e-06	8.83e-05	CbGpPWpGaD
Prednisolone—CYP2A6—Metabolism—PIK3CA—esophageal cancer	5.77e-06	8.35e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PTGS2—esophageal cancer	5.58e-06	8.08e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—EP300—esophageal cancer	4.64e-06	6.72e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—CREBBP—esophageal cancer	4.2e-06	6.08e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—NOS3—esophageal cancer	3.76e-06	5.44e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PTGS2—esophageal cancer	3.44e-06	4.98e-05	CbGpPWpGaD
Prednisolone—ABCB1—Metabolism—PIK3CA—esophageal cancer	3.43e-06	4.97e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—EP300—esophageal cancer	2.86e-06	4.14e-05	CbGpPWpGaD
Prednisolone—CYP3A4—Metabolism—PIK3CA—esophageal cancer	2.11e-06	3.06e-05	CbGpPWpGaD
